The Company enters 2026 with Multiple Phase 2 Catalysts, AI-enabled drug development strategy, and regulatory optionality as ...

Autonomous vehicles have made remarkable progress over the past decade. Driverless cars and buses that once struggled to stay ...

High probability of technical success in pivotal Phase 3 trial based on unmatched efficacy data for third-line non-small cell lung cancer (NSCLC) ...

High probability of technical success in pivotal Phase 3 trial based on unmatched efficacy data for third-line non-small cell lung cancer (NSCLC) treatment FDA's Fast Track designation for ateganosine ...

Energy Transfer's common units offer greater upside and an 8.04% yield, but its Series I Preferred provides stability and a 7 ...

Some 3,000 members of the opposition group Mujahedeen-e-Khalq (MEK) of Iran are sheltering in Albania. It has been claimed that the group plays an important role in the protests in Iran. Some experts ...

Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance Treg function, releases the following letter to ...

Hall was responding to a push by a group of south-west Queensland councils to explore underwriting a mutual-style insurance vehicle, amid mounting community anger about flood-driven premium spikes in ...

Scientists aim to build the first graviton detector to explore gravity's quantum nature, despite significant challenges.

Private wealth management in Asia and the Middle East has long been built on relationship depth, trusted networks, and the ...

Explore current market trends in sports betting apps, compare key features, and understand how platforms evolve with technology, user demand, and regulatory changes ...

Sports and digital culture have always evolved side by side, but the relationship between fans, media, and data has never ...